Recombinant HLA-DRB (Apolizumab Biosimilar) antibody
The Humanized Chimeric anti-HLA-DRB (Apolizumab Biosimilar) antibody (ABIN7597514) specifically detects HLA-DRB (Apolizumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597514
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant HLA-DRB (Apolizumab Biosimilar) antibody (ABIN7597514)
Target
HLA-DRB (Apolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Apolizumab Biosimilar Antibody
-
Specificity
- HLA class II histocompatibility antigen, DRB1 beta chain, Human leukocyte antigen DRB1, HLA-DRB1
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.22 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- HLA-DRB (Apolizumab Biosimilar)
-
Alternative Name
- Apolizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- HLA class II histocompatibility antigen, DRB1 beta chain, Human leukocyte antigen DRB1, HLA-DRB1
-
UniProt
- P01911
-
CAS-No
- 267227-08-7
Target
-
You are here:
